Corrigendum to: Revealing the Future of Pharmacovigilance in Precision Pharmaceutical Monitoring.
文献摘要
Following publication of the article entitled "Revealing the Future of Pharmacovigilance in Precision Pharmaceutical Monitoring" [1], certain phrases and expressions were identified that were unclear or inconsistent with established scientific terminology. To ensure accuracy and clarity of the published record, these expressions have been corrected using terminology that more accurately conveys the intended scientific meaning. These corrections are limited to the wording and terminology of the affected passages and do not alter the data, results, scientific interpretations, or conclusions of the article. The specific corrections are provided below: Table 1, Column 3, Row 6 Original text: In order to quantify the complexity of coronary illness and detect major cardiovascular events, this research focused on metabolomics indicators [74]. Corrected text: In order to quantify the complexity of coronary artery disease and detect major cardiovascular events, this research focused on metabolomics indicators [74]. The original article has been updated accordingly. This corrigendum is published to ensure transparency and accuracy of the scholarly record. The correct version of the article is available online at: https://www.eurekaselect.com/article/147119 The authors regret these errors and apologise for any inconvenience they may have caused.